OpenURL Connection Search

Select item for more details and to access through your institution.

Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey of Adults with Psoriasis in the United States.
Published in:
Dermatology & Therapy, 2024, v. 14, n. 7, p. 1839, doi. 10.1007/s13555-024-01190-4
By:
- Greiling, Teri;
- Young, Melodie;
- Seal, Melissa S.;
- Higham, Robert C.;
- Armstrong, April
Publication type:
Article
640 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis.
Published in:
British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.021
By:
- Bunick, Christopher G;
- Bhatia, Neal;
- Rosso, James Del;
- Draelos, Zoe D;
- Eichenfield, Lawrence F;
- Kircik, Leon H;
- Lebwohl, Mark G;
- Gooderham, Melinda;
- Green, Lawrence J;
- Hebert, Adelaide A;
- Vender, Ronald B;
- Zirwas, Matthew;
- Simpson, Eric L;
- Gold, Linda Stein;
- Seal, Melissa;
- Snyder, Scott;
- Osborne, David W;
- Burnett, Patrick;
- Higham, Robert C;
- Chu, David H
Publication type:
Article
638 - Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial.
Published in:
British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.019
By:
- Simpson, Eric L;
- Eichenfield, Lawrence F;
- Papp, Kim A;
- Forman, Seth;
- Hebert, Adelaide A;
- Gonzalez, Mercedes E;
- Gooderham, Melinda;
- Hong, H Chih-ho;
- Prajapati, Vimal H;
- Guttman, Emma;
- Silverberg, Jonathan;
- Seal, Melissa;
- Krupa, David;
- Burnett, Patrick;
- Synder, Scott;
- Chu, David H;
- Higham, Robert C;
- Berk, David R
Publication type:
Article
Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis.
Published in:
British Journal of Dermatology, 2024, v. 190, p. ii9, doi. 10.1093/bjd/ljad498.012
By:
- Bunick, Christopher G.;
- Bhatia, Neal;
- Rosso, James Del;
- Draelos, Zoe D.;
- Eichenfield, Lawrence F.;
- Kircik, Leon H.;
- Lebwohl, Mark G.;
- Gooderham, Melinda;
- Green, Lawrence J.;
- Hebert, Adelaide A.;
- Vender, Ronald B.;
- Zirwas, Matthew;
- Simpson, Eric L.;
- Gold, Linda Stein;
- Seal, Melissa;
- Snyder, Scott;
- Osborne, David W.;
- Burnett, Patrick;
- Higham, Robert C.;
- Chu, David H.
Publication type:
Article

Found: 4

Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey of Adults with Psoriasis in the United States.

640 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis.

638 - Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial.

Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis.